Evaluating Outcomes of Mother-Infant Pairs Using Dolutegravir for Treatment of HIV During Pregnancy

BACKGROUND: Dolutegravir (DTG) is a highly efficacious and well tolerated antiretroviral (ART) for the treatment of HIV infection. Although on the preferred treatment list for people living with HIV, it is not a treatment option for pregnant women because data on efficacy, tolerability during pregna...

Full description

Saved in:
Bibliographic Details
Published in:Open Forum Infect Dis
Main Authors: Sibliss, Kedesha, Kirby, Olivia, Nkwihoreze, Hervette, Aaron, Erika, Alleyne, Gregg, Momplaisir, Florence
Format: Artigo
Language:Inglês
Published: Oxford University Press 2017
Subjects:
Abstracts
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5631320/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofx163.1775
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items